A ribonucleoprotein-based decaplex CRISPR/Cas9 knockout strategy for CHO host engineering.

Joseph Carver1, Marie Kern1, Peggy Ko1

  • 1Cell Culture and Bioprocess Operations, Genentech, Inc., South San Francisco, California, USA.

Biotechnology Progress
|September 19, 2021
PubMed
Summary

This study presents a new CRISPR/Cas9 method for efficiently knocking out up to 10 genes in Chinese hamster ovary (CHO) cells. The sequential transfection approach speeds up multiplex gene editing for cell engineering.